Neurogene
NGNE
NGNE
39 hedge funds and large institutions have $384M invested in Neurogene in 2017 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 14 increasing their positions, 17 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
40% less funds holding in top 10
Funds holding in top 10: 5 → 3 (-2)
57% less call options, than puts
Call options by funds: $412K | Put options by funds: $950K
63% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 8
Holders
39
Holding in Top 10
3
Calls
$412K
Puts
$950K
Top Buyers
| 1 | +$25.2M | |
| 2 | +$6.64M | |
| 3 | +$430K | |
| 4 |
AP
Archon Partners
Princeton Junction,
New Jersey
|
+$209K |
| 5 |
Group One Trading
Chicago,
Illinois
|
+$199K |
Top Sellers
| 1 | -$3.75M | |
| 2 | -$2.51M | |
| 3 | -$2.14M | |
| 4 |
Franklin Resources
San Mateo,
California
|
-$1.2M |
| 5 |
HighTower Advisors
Chicago,
Illinois
|
-$839K |